respirerx pharmaceuticals

https://www.globenewswire.com/news-release/2016/04/01/1087345/0/en/RespireRx-Pharmaceuticals-Inc-the-University-of-Alberta-and-the-University-of-Florida-Provide-Update-on-Collaborative-Research-Activities.html RespireRx Pharmaceuticals Inc., the University of Alberta Use of Ampakines as a Novel Therapy for Overcoming Central Respiratory Depression ... respirerx pharmaceuticals the university inc alberta https://www.globenewswire.com/news-release/2017/06/14/1088053/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-the-2017-Marcum-MicroCap-Conference.html RespireRx Pharmaceuticals Inc. to Present at the 2017 CEO to review: dronabinol, a Phase 3-ready medicine for the treatment of obstructive sleep apnea; and ampakines, Phase 2 drug candidates for... respirerx pharmaceuticals inc present 2017 https://www.globenewswire.com/news-release/2016/02/04/1087291/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-18th-Annual-BIO-CEO-Investor-Conference.html RespireRx Pharmaceuticals Inc. to Present at 18th Annual GLEN ROCK, NJ--(Marketwired - Feb 4, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc present 18th annual https://www.globenewswire.com/news-release/2017/08/25/1122122/0/en/RespireRx-Pharmaceuticals-Inc-Files-June-30-2017-Quarterly-Report-on-Form-10-Q-And-Provides-Update.html RespireRx Pharmaceuticals Inc. Files June 30, 2017 GLEN ROCK, NJ--(Marketwired - Aug 25, 2017) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals june 30 inc files 2017 https://www.globenewswire.com/news-release/2016/06/08/1087423/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-the-Jefferies-2016-Healthcare-Conference.html RespireRx Pharmaceuticals Inc. to Present at the Jefferies GLEN ROCK, NJ--(Marketwired - Jun 8, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc present jefferies https://www.globenewswire.com/news-release/2016/09/13/1087555/0/en/UPDATE-RespireRx-Pharmaceuticals-Inc-Announces-Preliminary-Top-Line-Analysis-of-Data-From-Duke-University-Phase-2A-Clinical-Trial-of-CX1739.html UPDATE - RespireRx Pharmaceuticals Inc. Announces RespireRx Reports Safety and Efficacy Data ... respirerx pharmaceuticals update inc announces https://www.globenewswire.com/news-release/2016/01/19/1087276/0/en/RespireRx-Pharmaceuticals-Inc-Announces-New-Research-Program-With-the-National-Institute-of-Drug-Abuse.html RespireRx Pharmaceuticals Inc. Announces New Research RespireRx Expands Research Initiatives Involving Treatments for Drugs of Abuse ... respirerx pharmaceuticals inc announces new research https://www.biospace.com/corrected-headline-respirerx-pharmaceuticals-up-listed-to-otcqb-and-ticker-returns-to-rspi Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI -... Feb 9, 2021 - RespireRx Pharmaceuticals Inc., has been up listed from the OTC Pink Market and returns to the OTCQB Venture Market, effective with opening of the markets ,... respirerx pharmaceuticals https://www.globenewswire.com/news-release/2016/03/29/1087339/0/en/RespireRx-Pharmaceuticals-Inc-Files-December-31-2015-Annual-Report-on-Form-10-K.html RespireRx Pharmaceuticals Inc. Files December 31, 2015 Provides Update on Current Operations and Plans for 2016 ... respirerx pharmaceuticals december 31 inc files 2015 https://www.globenewswire.com/news-release/2017/02/10/1087797/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-BIO-CEO-Investor-Conference-2017.html RespireRx Pharmaceuticals Inc. to Present at BIO CEO & CEO to review dronabinol, a Phase 3-ready medicine for the treatment of obstructive sleep apnea, and provide pipeline update ... respirerx pharmaceuticals inc present bio ceo https://www.globenewswire.com/news-release/2016/12/23/1087721/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Positive-Results-from-Phase-2B-PACE-Study-Conducted-by-the-University-of-Illinois-Dronabinol-Reduces-Symptoms-of-Obstructive-Sleep-Apnea.html RespireRx Pharmaceuticals Inc. Announces Positive Results GLEN ROCK, NJ--(Marketwired - Dec 23, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc announces positive results https://www.globenewswire.com/news-release/2016/08/15/1087509/0/en/RespireRx-Pharmaceuticals-Inc-Files-June-30-2016-Quarterly-Report-on-Form-10-Q.html RespireRx Pharmaceuticals Inc. Files June 30, 2016 GLEN ROCK, NJ--(Marketwired - Aug 15, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals june 30 inc files 2016 https://www.globenewswire.com/news-release/2016/01/19/1087277/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-Noble-Financial-Capital-Markets-Twelfth-Annual-Investor-Equity-Conference-NobleCon12.html RespireRx Pharmaceuticals Inc. to Present at Noble GLEN ROCK, NJ--(Marketwired - Jan 19, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc present noble https://www.globenewswire.com/news-release/2016/02/29/1087301/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Removal-of-FDA-Clinical-Hold-on-CX1739-and-Initiation-of-Phase-2A-Clinical-Trial-by-March-31-2016.html RespireRx Pharmaceuticals Inc. Announces Removal of FDA GLEN ROCK, NJ--(Marketwired - Feb 29, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (OTC QB: RSPI as of January 11, 2016; previously OTC QB:... respirerx pharmaceuticals inc announces removal fda https://www.globenewswire.com/news-release/2016/09/08/1087548/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-the-Rodman-Renshaw-18th-Annual-Global-Investment-Conference-on-September-12-2016.html RespireRx Pharmaceuticals Inc. to Present at the Rodman & GLEN ROCK, NJ--(Marketwired - Sep 8, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc present rodman https://respirerx.com/ RespireRx Pharmaceuticals Inc. respirerx pharmaceuticals inc https://www.globenewswire.com/news-release/2016/10/04/1087582/0/en/RespireRx-Pharmaceuticals-Inc-Retracts-Efficacy-Data-in-September-12-2016-Press-Release-Announcing-Preliminary-Top-Line-Analysis-of-Safety-and-Efficacy-Data-From-Duke-University-Ph.html RespireRx Pharmaceuticals Inc. Retracts Efficacy Data in Data Is in Process of Being Re-Analyzed Updated Report Expected to Be Issued by the End of 2016 ... respirerx pharmaceuticals inc retracts efficacy data https://www.globenewswire.com/news-release/2016/07/13/1087455/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-the-Cantor-Fitzgerald-2nd-Annual-Healthcare-Conference-on-July-13-2016.html RespireRx Pharmaceuticals Inc. to Present at the Cantor GLEN ROCK, NJ--(Marketwired - Jul 12, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc present cantor https://www.globenewswire.com/news-release/2016/12/15/1087705/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Data-for-CX1739-Clinical-Study-in-Opioid-Induced-Respiratory-Depression.html RespireRx Pharmaceuticals Inc. Announces Data for CX1739 GLEN ROCK, NJ--(Marketwired - Dec 15, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc announces data cx1739 https://www.globenewswire.com/news-release/2016/03/11/1087312/0/en/RespireRx-Pharmaceuticals-Inc-to-Present-at-the-28th-Annual-Roth-Conference-on-March-15-2016.html RespireRx Pharmaceuticals Inc. to Present at the 28th GLEN ROCK, NJ--(Marketwired - Mar 11, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ( respirerx pharmaceuticals inc present 28th

Robuta